Oskar Hansson
Oskar Hansson
Professor of Neurology, Lund University
Adresse e-mail validée de med.lu.se - Page d'accueil
Citée par
Citée par
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson, H Zetterberg, P Buchhave, E Londos, K Blennow, L Minthon
The Lancet Neurology 5 (3), 228-234, 2006
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ...
Neuron 33 (6), 849-860, 2002
Cerebrospinal fluid levels ofβ-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
P Buchhave, L Minthon, H Zetterberg, ÅK Wallin, K Blennow, O Hansson
Archives of general psychiatry 69 (1), 98-106, 2012
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ...
Archives of neurology 67 (8), 949-956, 2010
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity
D Lindqvist, S Janelidze, P Hagell, S Erhardt, M Samuelsson, L Minthon, ...
Biological psychiatry 66 (3), 287-292, 2009
Improving the survival of grafted dopaminergic neurons: a review over current approaches
P Brundin, J Karlsson, M Emgård, GSK Schierle, O Hansson, Å Petersén, ...
Cell transplantation 9 (2), 179-195, 2000
Amyloid biomarkers in Alzheimer's disease
K Blennow, N Mattsson, M Schöll, O Hansson, H Zetterberg
Trends in pharmacological sciences 36 (5), 297-309, 2015
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ...
Archives of neurology 69 (11), 1445-1452, 2012
Caspase inhibition reduces apoptosis and increases survival of nigral transplants
GS Schierle, O Hansson, M Leist, P Nicotera, H Widner, P Brundin
Nature medicine 5 (1), 97-100, 1999
Prediction of Alzheimer’s disease using the CSF Aβ42/Aβ40 ratio in patients with mild cognitive impairment
O Hansson, H Zetterberg, P Buchhave, U Andreasson, E Londos, ...
Dementia and geriatric cognitive disorders 23 (5), 316-320, 2007
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
O Hansson, H Zetterberg, E Vanmechelen, H Vanderstichele, ...
Neurobiology of aging 31 (3), 357-367, 2010
Plasma tau levels in Alzheimer's disease
H Zetterberg, D Wilson, U Andreasson, L Minthon, K Blennow, J Randall, ...
Alzheimer's research & therapy 5 (2), 1-3, 2013
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography
S Palmqvist, H Zetterberg, K Blennow, S Vestberg, U Andreasson, ...
JAMA neurology 71 (10), 1282-1289, 2014
Expression of TGF‐β isoforms, TGF‐β receptors, and SMAD molecules at different stages of human glioma
C Kjellman, SP Olofsson, O Hansson, T Von Schantz, M Lindvall, I Nilsson, ...
International Journal of Cancer 89 (3), 251-258, 2000
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1-13, 2017
Transgenic mice expressing a Huntington’s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
O Hansson, Å Petersén, M Leist, P Nicotera, RF Castilho, P Brundin
Proceedings of the National Academy of Sciences 96 (15), 8727-8732, 1999
Plasma β-amyloid in Alzheimer’s disease and vascular disease
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...
Scientific reports 6 (1), 1-11, 2016
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
H Zetterberg, U Andreasson, O Hansson, G Wu, S Sankaranarayanan, ...
Archives of neurology 65 (8), 1102-1107, 2008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20